Exane Derivatives’s CNOVA N.V. CNV Stock Holding History

Exane Derivatives’s Portfolio CNV Stock Details CNV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,616	Closed	-$8.82K	–	714
2016 Q4	$8.82K	Buy	+1,616	New	+$8.78K	﹤0.01%	404

Other funds holding CNV

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Exane Derivatives's CNV Position: Q1 2017 in Review

Exane Derivatives sold out of CNOVA N.V. (CNV) in Q1 2017, closing a stake of 1,616 shares — an estimated $8.82K sold.

Exane Derivatives first reported a position in CNV in Q4 2016 and held it in 1 quarter. The position peaked at $8.82K in Q4 2016. 2 funds tracked by Wall St. Rank hold CNV as of Q1 2017.

Exane Derivatives reported no remaining CNOVA N.V. position as of Q1 2017 after selling out during the quarter.
Exane Derivatives sold 1,616 CNOVA N.V. shares in Q1 2017, an estimated $8.82K.
Exane Derivatives first reported a position in CNOVA N.V. in Q4 2016 and held it in 1 quarter.
Exane Derivatives's CNOVA N.V. position peaked at $8.82K in Q4 2016.
2 funds tracked by Wall St. Rank held CNOVA N.V. as of Q1 2017.

Based on Exane Derivatives's 13F filing for Q1 2017, filed 28 Apr 2017.